Zinc ion availability - The determinant of efficacy in zinc lozenge treatment of common colds

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 4, 1997, Pages 483-493

  Eby, George A ^a  

^a George Eby Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

ARTICLE; CLINICAL TRIAL; COMMON COLD; DOUBLE BLIND PROCEDURE; HUMAN; LOZENGE;

EID: 0030664568     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jac.a020864     Document Type: Article

References (54)

1. Eby, G. A., Davis, D. R. & Halcomb, W. W. (1984). Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrobial Agents and Chemotherapy 25, 20-4.
2. Al-Nakib, W., Higgins, P. G., Barrow, I., Batstone, G. & Tyrrell, D. A. J. (1987). Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. Journal of Antimicrobial Chemotherapy 20, 893-901.
3. Potter, Y. J. & Hart, L. L. (1993). Zinc lozenges for treatment of common colds. Annals of Pharmacotherapy 27, 589-92.
4. Johnston, S. L., Sanderson, G., Pattermore, P. K., Smith, S., Bardin, P. G., Bruce, C. B. et al. (1993). Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. Journal of Clinical Microbiology 31, 111-7.
5. Korant, B. D., Kauer, J. C. & Butterworth, B. E. (1974). Zinc ions inhibit replication of rhinoviruses. Nature 248, 588-90.
6. Korant, B. D. & Butterworth, B. E. (1976). Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. Journal of Virology 18, 298-306.
7. Butterworth, B. E., Grunert, R. R., Korant, B. D., Lonberg-Holm, K. & Yin, F. H. (1976). Replication of rhinoviruses. Archives of Virology 51, 169-89.
8. Korant, B. D. (1979). Role of cellular and viral proteases in the processing of picornavirus proteins. In The Molecular Biology of Picornaviruses (Perez-Bercoff, R., Ed.), pp. 149-73. Plenum Publishing, New York.
9. Butterworth, B. E. & Korant, B. D. (1974). Characterization of the large piconaviral polypeptides produced in the presence of zinc ion. Journal of Virology 74, 282-91.
10. Merluzzi, V. J., Cipriano, D., McNeil, D., Fuchs, V., Supeau, C., Rosenthal, A. S. et al. (1989). Evaluation of zinc complexes on the replication of rhinovirus 2 in-vitro. Research Communications in Chemical Pathology and Pharmacology 66, 425-40.
11. Geist, F. C., Bateman, J. A. & Hayden, F. G. (1987). In-vitro activity of zinc salts against human rhinoviruses. Antimicrobial Agents and Chemotherapy 31, 622-4.
12. ++-mediated induction of mitogenesis, cell-mediated cytotoxicity, and interferon production in murine lymphocytes. In Proceedings of the Fifteenth Leukocyte Culture Conference (Parker, J. W. & O'Brian, R. L., Eds), pp. 449-62. John Wiley, New York.
13. ++ induce cellular cytotoxicity and interferon production in murine T lymphocytes, Immunobiology 175, 455-69.
14. 2+. Clinical Immunology and Immunopathology 45, 139-42.
15. 2+. Bioscience Reports 7, 81-91.
16. Osol, A. (1980). Astringents and antiperspirants. In Remington's Pharmaceutical Sciences, 16th edn (Osol, A., Ed.), pp. 720-3. Mack Publishing, Easton, PA, USA,
17. Sugarman, B. (1983). Zinc and infection. Reviews of Infectious Diseases 5, 137-47.
18. Bashford, C. L., Alder, G. M., Menestrina, G., Micklem, K. J., Murphy, J. J. & Pasternak, C. A. (1986). Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations. Journal of Biological Chemistry 261, 9300-8.
19. Bashford, C. L., Menestrina, G., Henkart, P. A. & Pasternak, C. A. (1988). Cell damage by cytolysin. Spontaneous recovery and reversible inhibition by divalent cations. Journal of Immunology 141, 3965-74.
20. Bashford, C. L., Alder, G. M., Graham, J. M., Menestrina, G. & Pasternak, C. (1988). Ion modulation of membrane permeability: effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. Journal of Membrane Biology 103, 79-94.
21. 2+. BioEssays 6, 14-9.
22. Norris, D. (1985). Zinc and cutaneous inflammation. Archives of Dermatology 121, 985-9.
23. Chvapil, M., Stankova, L., Weldy, P., Bernhard, D., Campbell, J., Carlson, E. C. et al. (1977). The role of zinc in the function of some inflammatory cells. In Zinc Metabolism: Current Aspects in Health and Disease. (Brewer, G. J. & Prasad, A. S., Eds), pp. 103-22. Alan R. Liss, New York.
24. Smith, D. S., Helzner, E. C., Nuttall, C. E., Collins, M., Rofman, B. A., Ginsberg, D. et al. (1989). Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrobial Agents and Chemotherapy 33, 646-8.
25. Weismann, K., Jakobsen, J. P., Weismann, J. E., Hammer, U. M., Nyholm, S. M., Hansen, B. et al. (1990). Zinc gluconate lozenges for common cold. A double-blind clinical trial. Danish Medical Bulletin 37, 279-81.
26. Eby, G. A. (1994). Handbook for Curing the Common Cold - The Zinc Lozenge Story. George Eby Research, Austin, TX.
27. Douglas, R. M., Miles, H. B., Moore, B. W., Ryan, P. & Pinnock, C. B. (1987). Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrobial Agents and Chemotherapy 31, 1263-5.
28. Godfrey, J. C., Conant-Sloane, B., Smith, D. S., Turco, J. H., Mercer, N. & Godfrey, N. J. (1992). Zinc gluconate and the common cold: a controlled clinical study. Journal of International Medical Research 20, 234-46.
29. Farr, B. M., Conner, E. M., Betts, R. F., Oleske, J., Minnefor, A. & Gwaltney, J. M. (1987). Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrobial Agents and Chemotherapy 31, 1183-7.
30. Gupta, D. & Ho, P. S. (1988). Some formal aspects of diffusion. In Diffusion Phenomena in Thin Films and Microelectronic Materials. (Gupta, D. & Ho, P. S., Eds), pp. 1-16. Noyes Publications, Park Ridge, NJ, USA.
31. Adler, S. & Fraley, D. S. (1985). Acid-base regulation, cellular and whole body. In Fluid, Electrolyte, and Acid-base Disorders, Vol. 1, (Arieff A. I. & DeFronzo R. A., Eds), pp. 221-57. Churchill Livingstone, New York.
32. Guyton, A. C. (1986). Regulation of acid-base balance. Textbook of Medical Physiology, 7th edn, pp. 438-51. W. B. Saunders, New York.
33. Eby, G. A. (1995). The zinc lozenge and common cold story. In Handbook of Metal-Ligand Interactions in Biological Fluids, 2: Bioinorganic Medicine, Vol. 2 (Berthon, G., Ed.), pp. 1182-90. Marcel Dekker, New York.
34. Briggs, J., Finch, P., Matulewicz, M. C. & Weigel, H. (1981). Complexes of copper(II), calcium, and other metal ions with carbohydrates: thin-layer ligand-exchange chromatography and determination of relative stabilities of complexes. Carbohydrate Research 97, 181-8.
35. Gwaltney, J. M. (1979). Rhinovirus. In Principles and Practices of Infectious Diseases. (Mandell, G. L., Douglas, R. G. & Bennett, J. E., Eds), pp. 1124-34. John Wiley & Sons, New York.
36. Tucci, E. R., Ke, C. H. & Li, N. C. (1967). Linear free energy relationships for proton dissociation and metal complexation of pyrimidine acids. Journal of Inorganic Nuclear Chemistry 29, 1657-67.
37. Berthon, G. & Germonneau, P. (1982). Histamine as a ligand in blood plasma. Part 6. Aspartate and glutamate as possible partner ligands for zinc and histamine to favour histamine catabolism. Agents and Actions 12, 619-29.
38. Martin, R. B. (1988). pH as a variable in free zinc ion concentration from zinc-containing lozenges. Antimicrobial Agents and Chemotherapy 32, 608-9.
39. Berthon, G., May, P. M. & Williams, D. R. (1978). Computer simulation of metal-ion equilibria in biofluids. Part 2. Formation constants for zinc(II)-citrate-cysteinate binary and ternary complexes and improved models of low-molecular-weight zinc species in blood plasma. Journal of the Chemical Society, Dalton Transactions, 1433-8.
40. Berthon, G., Varsamidis, A., Blaquiere, C. & Rigal, D. (1987). Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand coordination. In-vitro tests on lymphocyte proliferation. Agents and Actions 22, 231-47.
41. Alemdaroglu, T. & Berthon, G. (1981). Trace metal requirements in total parenteral nutrition II. Potentiometric study of the metal-ion equilibria in the zinc-histidine, zinc-glycine, zinc-cysteine-histinidine, zinc-glycine-histidine and zinc-glycine-cysteine systems under physiological conditions. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry 128, 49-62.
42. Mossad, S. B., Macknin, M. L., Medendorp, S. V. & Mason, P. (1996). Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study. Annals of Internal Medicine 125, 81-8.
43. Prasad, A. S. (1996). Zinc: the biology and therapeutics of an ion. Annals of Internal Medicine 125, 142-4.
44. Cannan, R. K. & Kibrick, A. (1938). Complex formation between carboxylic acids and divalent metal cations. Journal of the American Chemical Society 60, 2314-20.
45. Furia, T. E. (1972). Sequestrants in food. In CRC Handbook of Food Additives, 2nd edn. (Furia, T. E., Ed.), pp. 271-94. CRC Press, West Palm Beach.
46. Windholz, M., Budavari, S., Blumetti, R. F. & Otterbein, E. S. (Eds) (1983). In The Merck Index, p. 1455. Merck, Rahway, NJ.
47. Struckhoff, G. & Heymann, E. (1986). Rat peritoneal mast cells release dipeptidyl peptidase II. Biochemistry Journal 236, 215-9.
48. Marone, G., Findley, S. R. & Lichtenstein, L. M. (1980). Modulation of basophil histamine release by zinc. Journal of Allergy and Clinical Immunology 65, 171.
49. Nordenström, B. E. (1983). Biologically Closed Electric Circuits. Clinical, Experimental and Theoretical Evidence for an Additional Circulatory System, pp. 112-73. Nordic Medical Publications, Stockholm.
50. Hacht, B. & Berthon, G. (1987). Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorganica Chimica Acta 136, 165-71.
51. Eby, G. A. (1992). Flavor stable zinc acetate compositions for oral absorption. US Patent no. 5,095,035.
52. Eby, G. A. (1991). Flavor stable zinc acetate compositions for oral absorption. International Patent Application PCT/ US91/09487.
53. Eby, G. A. (1995). Cure for common cold. US Patent no. 5,409,905.
54. Gwaltney, J. M., Park, J., Paul, R. A., Edelman, D. A., O'Connor, R. R. & Turner, R. B. (1996). Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clinical and Infectious Diseases 22, 656-62.